PORTSMOUTH, N.H., April 7,
2022 /PRNewswire/ -- Medical technology company,
Pneuma Systems Corporation, has entered a multi-faceted business
collaboration with West Pharmaceutical Services, Inc. (NYSE: WST)
with the goal of improving the patient's experience with drug
therapy.
West Pharmaceutical and Pneuma Systems
combine to disrupt drug therapy with dramatic safety and workflow
improvements
West is a leading global manufacturer in the design and
production of technologically advanced, high-quality, integrated
containment and delivery systems for injectable medicines. Pneuma
Systems Corporation has developed a family of fluid flow
technologies that are aimed at scientific and medical applications.
The global intravenous pump market segment is expected to reach
USD 20.5 billion over the next five
years.
Pneuma will provide a novel closed-loop fluid flow control
platform that West will use to develop drug delivery solutions for
pharmaceutical companies and clinical end users. West will provide
technical and financial support to Pneuma and access to the
emerging West Digital Platform, designed to improve transmission of
data and other information.
"West's almost century-long commitment to the development of
drug delivery systems dovetails with our cutting-edge flow control
technology. West's latest foray into a broad digital architecture
is very important to us. When you improve both fluid flow and
information flow, the result is an improvement in workflow, which
results in higher levels of patient safety and lower costs," said
Pneuma CEO Jeffrey Carlisle. "We are
aiming at disruptive improvements in workflow."
"We are excited about our collaboration with Pneuma and the
potential of their technologies to address a variety of flow
control challenges to drive improvements in healthcare. At West our
mission is to improve patient lives not only through our products
and services but also by investing in small innovative companies
and offering our deep technical and commercial expertise to help
them bring their transformation technologies to the market," added
Scott Young, VP Venture &
External Collaboration at West.
Pneuma Systems, together with its strategic partners, plans to
install PneumaDrive™ technology-based infusion devices in
infusion centers, home care, and acute care settings around the
world. The low cost PneumaDrive™ technology can replace
existing infusion pumps and automate "gravity drip" infusions,
providing patients with a safer and easier experience.
About Pneuma
Pneuma Systems is a New
Hampshire based company founded by Jeffrey Carlisle, also Founder of the recently
acquired Ivenix
(https://finance.yahoo.com/news/ivenix-acquired-fresenius-kabi-072600696.html).
Pneuma is dedicated to improving fluid flow, information flow, and
workflow for the IV therapy process. For more information,
visit www.pneuma-systems.com.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With
approximately 10,000 team members across 50 sites worldwide, West
helps support our customers by delivering over 45 billion
components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a
century, West in its fiscal year 2021 generated $2.83
billion in net sales. West is traded on the New York Stock
Exchange (NYSE: WST) and is included on the Standard & Poor's
500 index. For more information,
visit www.westpharma.com.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or
its subsidiaries, in the United States and other
jurisdictions, unless otherwise noted.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pneuma-systems-collaborates-with-west-pharmaceutical-services-inc-to-improve-the-patient-experience-301519643.html
SOURCE Pneuma Systems Corporation